Search For "gilead sciences"
South Korean shipping stocks weaken on tariff worries
Updated : 7 months, 3 weeks ago IST
South Korean shipping stocks fell on Tuesday as investors fretted over a prolonged global trade slowdown tied to U.S. tariff policies, while Hanmi Pharmaceutical rose after announcing a technology transfer deal with Gilead Sciences, the Pulse, the English service of Maeil Business Newspaper
Read More
Consignment of 200,000 Amphotericin B doses used in black fungus treatment
Updated : 4 years, 12 months ago IST
New Delhi [India], May 30 (ANI): A consignment of 200,000 AmBisome (Amphotericin B injection), used in black fungus treatment reached India on early Sunday.
Read More
COVID-19: Another 29,021 vials of Remdesivir sent by Gilead Sciences reach
Updated : 5 years ago IST
Mumbai (Maharashtra) [India], May 15 (ANI): American pharmaceutical company Gilead Sciences sent another 29,021 vials of antiviral drug Remdesivir to India on Saturday in a bid to help the country fight the deadly second wave of COVID-19 pandemic.
Read More
Third consignment of 25000 doses of Remdesivir from Gilead sciences reache
Updated : 5 years ago IST
New Delhi [India], May 8 (ANI): The third consignment consisting of 25000 doses of Remdesivir from American biopharmaceutical company Gilead Sciences reached India on Saturday.
Read More
Gilead Sciences gifts another 25,600 vials of Remdesivir to India
Updated : 5 years ago IST
New Delhi [India], May 8 (ANI): India thanked American biopharmaceutical company Gilead Sciences on Saturday for gifting another 25,600 vials of Remdesivir, which is used in the treatment of COVID-19 patients.
Read More
Gilead to give licensees in India support to open more Remdesivir manuf
Updated : 5 years ago IST
California [US], April 29 (ANI/Sputnik): US-based Gilead Sciences Inc company, the developer of antiviral drug Remdesivir, used for treatment of COVID-19 patients, will provide all its licensing partners in coronavirus-hit India with the technical support for the addition of new manufacturin
Read More
US FDA approves remdesivir, first drug to treat COVID-19 patients
Updated : 5 years, 7 months ago IST
Washington [US], October 23 (ANI): The United States Food and Drug Administration (FDA) has approved Remdesivir for the treatment of coronavirus, Al Jazeera reported citing a statement issued by Gilead Sciences, Inc.
Read More
Dr Reddy's launches Redyx (Remdesivir) in India for COVID-19 treatment
Updated : 5 years, 8 months ago IST
Hyderabad (Telangana) [India], September 9 (ANI): Dr Reddy's Laboratories on Wednesday announced the launch of Remdesivir under the brand name Redyx for Indian markets.
Read More
At Rs 2,800, Zydus launches Remdac for treatment of COVID-19 in India
Updated : 5 years, 9 months ago IST
Ahmedabad (Gujarat) [India], Aug 13 (ANI): Pharmaceutical major Zydus Cadila said on Thursday it has launched Remdesivir under the brand name Remdac for treatment of COVID-19 in the Indian market.
Read More
Jubilant launches Remdesivir in India for treatment of COVID-19
Updated : 5 years, 9 months ago IST
Noida (Uttar Pradesh) [India], Aug 4 (ANI): Jubilant Life Sciences has launched Remdesivir for injection under the brand name JUBI-R in Indian market at a price of Rs 4,700 per vial of 100 mg and said it will make the drug available to over 1,000 hospitals providing COVID-19 treatment throug
Read More
Mylan gets DCGI nod for remdesivir in India, to launch at Rs 4,800 per via
Updated : 5 years, 10 months ago IST
Bengaluru (Karnataka) [India], July 7 (ANI): Global pharmaceutical major Mylan has got approval for its remdesivir from the Drug Controller General of India (DCGI) and will launch a generic version of Gilead Sciences' COVID-19 anti-viral in the country at Rs 4,800 for 100 mg/vial.
Read More
Gilead Sciences to start trials of inhaled version of remdesivir
Updated : 5 years, 11 months ago IST
California [USA], June 23 (ANI): US-based biopharmaceutical major Gilead Sciences will soon start clinical trials for inhaled formulation of its anti-viral drug remdesivir used for the treatment of Covid-19.
Read More